Purdue Hits 2 Generics Makers With OxyContin Patent Suits
News | 31 January 2013
Law360, New York (January 31, 2013, 4:24 PM ET) -- Purdue Pharma LP on Wednesday sued two generic drugmakers in New York federal court, alleging their planned generic versions of painkiller OxyContin infringed several patents covering the drug.
Click on the link to read the full article at Law360 (subscription)
(This link will open in a new window)
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
